ConserV Bioscience-preview

Conservbio

ConserV Bioscience

Private

LondonHealthcare & Life Scienceshttps://conservbio.com

Last Round

Grant

Jul 7, 2025

Total Funding Raised

$3.59M

Momentum Score

25 /100

Company Overview

ConserV Bioscience is a biotechnology company that develops vaccines designed to protect against endemic and emergent infectious diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2G

Customer Profile

Government Contracts

AI Layer

Non-AI

Keywords

broadly protective vaccinesuniversal vaccinesin silico vaccine designT-cell vaccinebioinformatics platformconserved epitopesvaccine developmentpan-coronavirus vaccinebroad-spectrum influenza vaccineclinical-stage biotechantigen identificationmRNA vaccinesinfectious disease vaccinesepidemic preparednessarbovirus vaccinegovernment contracts

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

ConserV Bioscience Comps

Public and private peers based on sector, stage, and business model.

Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

ConserV Bioscience Funding Rounds

Historical fundraising activity

Round	Date	Amount Raised	Valuation	Investors	Sources
Grant	Jul 7, 2025
Grant	Jan 16, 2024
Grant	Jan 1, 2024
Grant	Mar 1, 2023
Grant	Mar 1, 2022
Grant	Feb 24, 2022

View all Funding Rounds

Key People

Founding team and executive leadership

Kimbell Duncan

Chief Executive Officer, Board Member

Executive Team

Declan Monaghan

Chief Financial Officer

Executive Team

ConserV Bioscience Investors

Notable investors and investment history

Investor	Rounds
Innovate UK	Grant
European Commission (Horizon Europe)	Grant
European Commission	Grant
DHSC	Grant
UK Vaccine Network	Grant

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Apr 23, 2026
Monthly visitors increased 141% MoM, from 517 to 1.2K.

View all signals

ConserV Bioscience Filings

SEC and related filings with document metadata.

Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

ConserV Bioscience Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about ConserV Bioscience's valuation, stock price, and market status.

Firmographic Details

HeadquartersLondon

Employee Range1

Year Founded2020

Last FundingJul 7, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.